Latest Conference Coverage


Future Plans for ALZ-801 in Homo- and Heterozygous Populations: Susan Abushakra, MD

January 27th 2023

The chief medical officer at Alzheon provided perspective on the next steps for ALZ-801 following a successful phase 2 study of patients with APOE ε4/4 or APOE ε3/4 genotype. [WATCH TIME: 2 minutes]


Building Trust in the Epilepsy Clinician-Patient Relationship: Elizabeth Felton, MD, PhD

January 20th 2023

The assistant professor in the Department of Neurology at the University of Wisconsin spoke about healthcare providers establishing trust with their patients and improving health equity. [WATCH TIME: 3 minutes]


Post-Stroke Seizure Predictive Models, SeLECT Model: Carolina Ferreira Atuesta, MD, MSc

January 18th 2023

The scientific researcher and clinical manager, Icahn School of Medicine at Mount Sinai, spoke about the clinical models used to predict seizures in poststroke patients. [WATCH TIME: 4 minutes]


Influence of Antiepileptic Medications on Seizure Frequency in Insomnia: Milena Pavlova, MD

January 18th 2023

At the 2022 AES annual meeting, the associate professor at Harvard Medical School and neurologist at the Brigham and Women's Hospital talked about seizure frequency and insomnia. [WATCH TIME: 2 minutes]


Poststroke Epilepsy Management With Antiseizure Medication: Carolina Ferreira Atuesta, MD, MSc

January 15th 2023

At the 2022 AES Conference, the scientific researcher and clinical manager at the Icahn School of Medicine at Mount Sinai talked on seizure management with medication in poststroke patients. [WATCH TIME: 3 minutes]


Understanding ALZ-801’s Impact on Alzheimer Pathologies, Brain Atrophy

January 14th 2023

Susan Abushakra, MD, chief medical officer at Alzheon, provided insight on findings from a phase 2 study in which ALZ-801 showed beneficial effects on cognition, Aß 42/40, and brain atrophy.


Worse Clinical Outcomes, Higher Mortality Rates, and Shorter Lifespans in Epilepsy and Dementia: Ifrah Zawar, MD

January 11th 2023

The assistant professor of neurology at the University of Virginia spoke at the 2022 AES Conference about clinical outcomes of patients with dementia who experience seizures. [WATCH TIME: 5 minutes]


Poststroke Epilepsy and Cerebrovascular Disease: Carolina Ferreira Atuesta, MD, MSc

January 11th 2023

The scientific researcher and clinical manager at the Icahn School of Medicine at Mount Sinai, spoke about a talk given at the 2022 AES conference on seizures after ischemic. [WATCH TIME: 5 minutes]


NeuroVoices: RJ Tesi, MD, on XPro1595 and the Role of TNF Inhibitors in the Alzheimer Field

January 11th 2023

The president and chief executive officer of INmune bio provided perspective on the need to diversify the Alzheimer treatment landscape and the potential role of TNF inhibitors like XPro1595.


Difference Between Health Equity and Health Disparities in Epilepsy: Elizabeth Felton, MD, PhD

January 10th 2023

The assistant professor in the Department of Neurology at the University of Wisconsin spoke about the differences between health disparities and health equity in epilepsy care at the 2022 AES Conference. [WATCH TIME: 3 minutes]


Debating Surgery in Genetic Disorders with Epilepsy: Scott Perry, MD

January 9th 2023

The head of neurosciences at the Jane and John Justin Neurosciences Center of Cook Children’s Medical Center spoke about his experience in a debate on surgery in genetic disorders at the 2022 AES Conference. [WATCH TIME: 3 minutes]


The Definition of a Seizure, Clinical Controversies: Michael Sperling, MD

January 8th 2023

The Baldwin Keyes professor of neurology at Thomas Jefferson University, spoke with us at the 2022 AES Conference about the definition of a seizure. [WATCH TIME: 3 minutes]


Results from the Subgroup Analysis of BECOME Caregiver Survey: Robert Iannone, MD, MSCE

January 6th 2023

The executive vice president of Global Head of Research and Development at Jazz Pharmaceuticals, spoke on the results from the BECOME study presented at the 2022 AES Conference. [WATCH TIME: 6 minutes]


Rare Epilepsies, Comorbidities, and Genetic Therapies: Danielle Andrade, MD, MSc, FRCPC

January 5th 2023

The professor of neurology at the University of Toronto talked about 3 conditions that were discussed during the epilepsy therapies symposium at the 2022 AES Conference. [WATCH TIME: 5 minutes]


Creating Innovative Ways to Improve Alzheimer Disease Prevention: Miia Kivipelto, MD, PhD

January 4th 2023

The professor of clinical geriatric epidemiology at Karolinska Institutet discussed strategies for lowering the risk of Alzheimer disease, and the new ways to approach prevention. [WATCH TIME: 4 minutes]


Genetic Approaches to Comorbidities in Epilepsy, Dravet Syndrome: Danielle Andrade, MD, MSc, FRCPC

January 4th 2023

The professor of neurology at the University of Toronto spoke at the 2022 AES Conference about genetic approaches to comorbidities for patients with epilepsy. [WATCH TIME: 5 minutes]


Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhD

January 3rd 2023

The director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]


Understanding the Long-Term Role of Brain-Derived Neurotrophic Factor Following Lifestyle Changes: Miia Kivipelto, MD, PhD

January 2nd 2023

The professor of clinical geriatric epidemiology at Karolinska Institutet discussed a subgroup analysis of the FINGERS trial and the clinical utility of the precursor to serum brain-derived neurotrophic factor. [WATCH TIME: 3 minutes]


Need for a Multifactoral Approach to Treat Alzheimer Disease: Nicolas Villain, MD

January 2nd 2023

The cognitive and behavioral neurology fellow at Pitié-Salpêtrière Hospital in Paris, France, provided perspective on the reasons to not solely rely on anti-amyloid treatments to treat Alzheimer disease. [WATCH TIME: 3 minutes]


Sleep Studies Determine Sleep Disorders in Patients with Epilepsy: Milena Pavlova, MD

December 25th 2022

At the 2022 AES annual meeting, the associate professor at Harvard Medical School and neurologist at the Brigham and Women's Hospital talked about sleep testing for patients with epilepsy. [WATCH TIME: 3 minutes]


Interactions Between Sleep Disorders and Epilepsy in Adults: Milena Pavlova, MD

December 22nd 2022

The associate professor at Harvard Medical School and neurologist at the Brigham and Women's Hospital spoke about sleep disorders and epilepsy in adults at the 2022 AES annual meeting. [WATCH TIME: 5 minutes]


Tempering Expectations on High-Clearance Anti-Amyloid Immunotherapies in Alzheimer Disease: Nicolas Villain, MD

December 21st 2022

The cognitive and behavioral neurology fellow at Pitié-Salpêtrière Hospital in Paris, France, provided background on a study presented at CTAD 2022 assessing the efficacy of prominent, up-and-coming anti-amyloid therapies. [WATCH TIME: 7 minutes]


NeuroVoices: Miia Kivipelto, MD, PhD, on Using Multidomain Interventions to Prevent Cognitive Decline

December 21st 2022

The professor of clinical geriatric epidemiology at Karolinska Institutet provided perspective on the FINGERS trial, the first study to show it is possible to prevent cognitive decline using a multidomain lifestyle intervention.


Understanding the Safety Profile of ALZ-801 in High-Risk Alzheimer Disease: Susan Abushakra, MD

December 20th 2022

The chief medical officer of Alzheon detailed the phase 2 safety findings of ALZ-801, and the lack of amyloid-related imaging abnormalities observed. [WATCH TIME: 3 minutes]


Recognizing Health Disparities in Infantile Spasms at Local and National Levels: Kerri Neville, MD

December 19th 2022

The pediatric neurologist and epileptologist at the University of Michigan's Mott Children's Hospital spoke at the 2022 AES conference about disparities that currently exist in epilepsy care. [WATCH TIME: 4 minutes]


Improving Biomarker Selection and Treating the Underlying Pathology of Dementia With Lewy Bodies

December 19th 2022

James Galvin, MD, MPH, director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine, provided insight on the unmet needs for dementia with Lewy bodies, and whether success in Alzheimer disease can help.

© 2023 MJH Life Sciences

All rights reserved.